A Private Consultation

An editorial guide to the ED care conversation

A reading publication. Not a clinic or patient portal.

Back to the reading library

Product review · Published October 7, 2026 · Updated October 7, 2026

Hims Daily Hard Mints review

Hims Daily Hard Mints: a daily regimen and the current identity of an older public offer, with formulation, cost, evidence and availability examined to prepare for assessment of one identifiable prescription.

Editorial document research · How we use sources

A consultation about Hims Daily Hard Mints should begin with what it actually contains and why it is being considered. The documented offer is a daily tadalafil Hard Mints listing on the dedicated chewable page. This review uses that specific preparation to organize questions about assessment, prescribing responsibility and follow-up, rather than treating a company's entire catalog as one treatment.

In this article

Keep this question in view

The important distinction is a daily regimen and the current identity of an older public offer. The unresolved question is whether this exact offer remains selectable for the account.

The exact product

The clinical decision includes a daily regimen and the current identity of an older public offer. Describe the symptom and prior treatment history before asking for the advertised product by name. The clinician may recommend another preparation or further assessment. A selected online package is not a completed prescription decision, and a familiar ingredient does not settle whether the proposed combination or format is appropriate. The record below identifies the offer without supplying use instructions.

DetailRecord
ProviderHims
Listed active ingredientsTadalafil; confirm the dispensed formula
Dosage formCompounded daily mint
Regulatory distinctionCompounded preparation; the finished product is not FDA-approved.
Source basisHims: Hard Mints chewable ED medicines · Hims: current ED treatment catalog

Price, supply and payment

It is reasonable to discuss affordability during assessment. The public figure for this product is From $39/month on the chewable page. Confirm what the first charge covers, what changes if a different prescription is recommended, and whether an assessment fee is separate. A quote for one supply should not be assumed to apply after a clinical adjustment. Ask for the accepted quantity, term and renewal amount once the actual treatment is known.

DetailRecord
Dedicated page headlineFrom $39/month
Catalog distinctionThe main catalog separately lists newer named chews
Confirmation neededComplete dispensed ingredients and current plan
Schedule distinctionDaily does not mean adding an occasion-based ED product independently

What the research can support

A useful prescribing explanation connects the patient's concern to relevant evidence. Here that evidence concerns daily tadalafil research rather than a trial of every mint formulation; it leaves whether this exact offer remains selectable for the account unsettled. Ask why the proposed preparation is being considered and what simpler or differently formulated options were evaluated. A marketing claim does not supply an individualized rationale, and clinician involvement does not transform evidence for one preparation into evidence for every related product.

DetailRecord
Evidence boundarydaily tadalafil research rather than a trial of every mint formulation
Not established herewhether this exact offer remains selectable for the account
Clinical and regulatory referencesMedlinePlus: Tadalafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Sildenafil

Safety questions for the prescriber

Bring a complete account of prescriptions, nonprescription products and intermittent medicine use. Specifically disclose nitrates or nitrites, riociguat, blood-pressure treatment and other ED medication. Relevant heart, kidney, liver and eye history may change the assessment. Do not stop an unrelated prescription or overlap Hims Daily Hard Mints with a previous ED product on your own. The clinician should provide individualized instructions for any transition.

DetailRecord
One active does not mean no interactionsNitrates/nitrites, riociguat and other medications require assessment even after previous ED treatment.

Availability and the actual prescription

The public access statement is Listed on the dedicated chewable-medicine page; confirm current plan. Service eligibility, a selectable plan and clinical suitability are different decisions. An online format may still require examination, testing or referral when the history calls for it. If a product is documented only in safety information, confirm whether the clinician can currently offer it before planning around that option or its historical price.

Refills, changes and cancellation

Before the consultation ends, ask how the response will be reviewed and who receives questions between orders. For this preparation, ask “Is the daily product offered to me the same formulation as this public listing?” Clarify what symptoms require prompt care and how an ordinary treatment adjustment reaches the pharmacy. The account team also needs to confirm any refill change. Neither a medical message nor a subscription setting alone proves the whole plan has been updated.

DetailRecord
Next chargeThe next order date is the charge/processing date; a first refill can be scheduled early.
Cancellation noticeAt least 48 hours before the next order, according to support guidance.
Already processingEnding a subscription does not cancel an order already processing or shipped.
Refund boundaryNo refund guaranteed after pharmacy processing.
Policy sourcesHims Support: canceling a subscription · Hims Support: refund policy · Hims Support: when billing occurs

Compare named products

The alternatives below can help articulate a preference or concern, but they are not a self-prescribing menu. Compare the exact ingredients, form and routine you would want to discuss. If several goals are bundled together, ask how each will be assessed. A different brand may offer a similar ingredient while a different product from the same brand may require an entirely new clinical explanation.

Questions to keep with the offer

This is a preparation aid based on records for Hims Daily Hard Mints, not a clinical assessment or a private patient portal. No consultation, prescribing decision or outcome was observed for the review, and there is no medical-review sign-off. Use the sources to ask clearer questions, while leaving the diagnosis, suitability and directions to the professionals responsible for your care.

DetailRecord
Ask about this formulaIs the daily product offered to me the same formulation as this public listing?
Ask about the paymentWhat are the exact quantity, total due now, renewal amount and notice deadline?
Ask about a changeWho confirms the medical instructions, pharmacy order and next account charge?

When to get urgent help

An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.

Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.

Source documents

Provider documents establish what is advertised. Clinical and regulatory documents have different roles and do not independently verify the provider’s actual care.

  1. Hims: Hard Mints chewable ED medicinesProvider source; compounded formulations and advertised starting prices · Checked 2026-10-07
  2. Hims: current ED treatment catalogProvider catalog; individual named offers and starting prices · Checked 2026-10-07
  3. Hims Support: canceling a subscriptionProvider policy; 48-hour notice and orders already processing · Checked 2026-10-07
  4. Hims Support: refund policyProvider policy; no guaranteed refund after pharmacy processing · Checked 2026-10-07
  5. Hims Support: when billing occursProvider policy; next order date, charge timing, and subscription intervals · Checked 2026-10-07
  6. Hims Support: changing the next order dateProvider support; refill rescheduling differs from cancellation · Checked 2026-10-07
  7. MedlinePlus: TadalafilDrug information; standard tadalafil products · Checked 2026-10-07
  8. FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications · Checked 2026-10-07
  9. DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination · Checked 2026-10-07
  10. MedlinePlus: SildenafilDrug information; standard sildenafil products · Checked 2026-10-07